Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dimensional ETF Trust Dimensional US High Profitability ETF (NY:DUHP)

38.47 +0.30 (+0.79%)
Official Closing Price Updated: 6:30 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dimensional ETF Trust Dimensional US High Profitability ETF

< Previous 1 2 Next >
Kroger Interim CEO Highlights Shift To Coupons, Private Labels Amid Economic Pressures: ‘Customers Are Feeling Stressed’
However, Ron Sargent also noted that Kroger was adding new households and growing order volumes with existing consumers who already shop with the grocer. 
Via Stocktwits
Topics Artificial Intelligence Economy
Delta CEO Says Consumer Confidence Recovers From ‘Big Impact’ Earlier This Year: Report
Via Stocktwits
Merck Reportedly Scraps Research Centre In UK: Retail Sees Stock Rallying To $97.50
Via Stocktwits
Eli Lilly Launches AI, Machine Learning Platform Called TuneLab For Biotech Companies
The platform will provide biotech companies access to drug discovery models trained on years of Lilly's research data, the company stated. 
Via Stocktwits
Topics Artificial Intelligence
Cardinal Health Opens Distribution Center In Texas, Plans One In California
The new Texas facility will ship approximately 10,000 packages containing critical medical supplies daily directly to people's homes nationwide. 
Via Stocktwits
GM Recalls Nearly 24,000 Chevrolet Corvette Vehicles In The US: Find Out Why
Via Stocktwits
Topics Product Recall
This Pharma Giant Is Set To Invest $2B To Expand Manufacturing In North Carolina, And It Just Received A Price Target Hike From Citi: Do You Own It?
Via Stocktwits
Apple Plans Tabletop Robot, Among Other AI Products, Says Report
Via Stocktwits
Topics Artificial Intelligence
Gilead Stock Showered With Upgrades, Price Target Hikes After Upbeat Q2, Guidance Lift: Retail’s Turned Exuberant
Via Stocktwits
Eli Lilly To Hike Mounjaro Prices By A Whopping 170% In UK: Retail Expects Stock To See Smooth Rally Till $720
According to the Financial Times, the price for a month’s supply of the highest doses of the drug will rise from £122 to £330, an increase of 170%. 
Via Stocktwits
Topics Government World Trade
Texas Sues Eli Lilly Over Bribery Allegations: Retail Focuses On Company’s Upbeat Performance
Texas Attorney General Ken Pax­ton alleged that Lilly offered illegal incentives to medical providers in Texas designed to steer providers toward prescribing Lilly’s drugs. 
Via Stocktwits
Topics Fraud Law Enforcement Lawsuit
GM Secures Rare Earth Magnet Supply From Texas Partner Amid Push to Mitigate Tariffs
Noveon Magnetics said that it began delivering magnets to support GM's full-size SUVs and trucks in July. 
Via Stocktwits
Topics Earnings Economy World Trade
GM More Than Doubles EV Sales In July Ahead Of Federal Tax Credit Expiry: Chevrolet Equinox EV Leads Pack
Via Stocktwits
Merck’s Full Year Guidance Disappoints Investors But Retail Pins Hopes On $3B Cost-Cutting Plan
The $3 billion will be reinvested to support new product launches and its pipeline across multiple therapeutic areas, Merck said. 
Via Stocktwits
Topics World Trade
GM’s Mary Barra Highlights Efforts To Mitigate Tariff Impact After Q2 Earnings Take Hit: Retail Sees Levies Impact Consumer Spending
Via Stocktwits
Retail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here's What Investors Are Thinking
Via Stocktwits
General Motors, LG Energy Solution JV To Upgrade Spring Hill Facility To Scale Low-Cost Battery Cell Making
Via Stocktwits
BMO Capital Has An Important Take On Gilead Sciences, Retail’s Keeping The Optimism Alive
The Supreme Court's Braidwood decision only concretized the power of the Department of Health and Human Services to decide what is necessary preventative care, rather than outright protecting... 
Via Stocktwits
Gilead Gets Analyst Thumbs Up On Market Potential Of HIV-Prevention Injection, But Retail’s Not Ready To Cheer Yet
Needham has a $133 price target on the stock, representing an upside of about 17.5% to the stock’s closing price on Thursday. 
Via Stocktwits
Topics Workforce
GM EV Production To Be Guided By Consumer Demand, Says CFO As Federal Tax Credits Near Expiry
GM CFO said that the company’s recent $4 billion investment in U.S. manufacturing over the next two years gives it the necessary capabilities to produce both internal combustion engine and electric... 
Via Stocktwits
Topics Government
AbbVie Enters Licensing Agreement For IGI Therapeutics’ Experimental Oncology Drug: Retail Cheers
Under the terms of the agreement, AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China. 
Via Stocktwits
Topics Product Recall
Gilead, Global Fund Enter Agreement To Supply HIV Prevention Drug To Low & Lower-Middle-Income Countries
Under the agreement, Gilead will supply enough doses of its Lenacapavir drug to reach up to two million people over three years in countries supported by the Global Fund, at no profit to the company. 
Via Stocktwits
Eli Lilly’s Alzheimer’s Drug Gets US FDA Label Update For More Gradual Dosing After Study Shows Reduced Side Effects
The U.S. FDA approved Kisunla, an amyloid-targeting therapy, in July 2024 after a study showed that it significantly slowed cognitive and functional decline in Alzheimer’s patients who were less... 
Via Stocktwits
Johnson & Johnson Submits Supplemental Drug Application To FDA For Schizophrenia Drug Caplyta
J&J gained access to Caplyta by the acquisition of Intra-Cellular Therapies, Inc., which was completed in April. 
Via Stocktwits
Topics Government
GM Stock Rises As US Sales Jump 7% In Q2, Powered By Crossovers
Chevrolet, the company’s biggest brand, witnessed a 5.7% increase in sales in the quarter to 478,322 units, owing to a jump in sales of its Silverado and Equinox vehicles. 
Via Stocktwits
AbbVie To Acquire Capstan Therapeutics For Up To $2.1 Billion To Boost Immunology Portfolio As Humira Sales Drop: Stock Gains In Morning Trade
The acquisition will include Capstan’s lead asset, called CPTX2309, in development for the treatment of B-cell-mediated autoimmune diseases. 
Via Stocktwits
Topics Intellectual Property
Gilead Stock Rises On US Supreme Court Ruling In Favor Of Health Insurers Covering Preventive Care
Jefferies termed the Supreme Court’s ruling an ‘incremental positive’ for Gilead that removes an overhang going into the launch for Yeztugo. 
Via Stocktwits
Trump HHS Pick Robert F. Kennedy Jr.'s Wealth Comes From Family, Law Practice, Oil, Bitcoin
Robert F. Kennedy Jr. owes portions of his wealth to his family name, law, cryptocurrency and oil. Here's a look at his wealth and income. 
Via Benzinga
Topics Government
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.